Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Fullmektig i EP:
2013.04.26, EP 13165582
GÜNTHER KRUMPL ET AL: "Pharmacodynamic and -kinetic Behavior of Low-, Intermediate-, and High-Dose Landiolol During Long-Term Infusion in Whites :", JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, vol. 70, no. 1, 1 July 2017 (2017-07-01), pages 42-51, XP055686060, NEW YORK, NY ISSN: 0160-2446, DOI: 10.1097/FJC.0000000000000495 (B1)
JU MIZUNO ET AL: "Age and sex-related differences in dose-dependent hemodynamic response to landiolol hydrochloride during general anesthesia", EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 63, no. 3, 9 January 2007 (2007-01-09), pages 243-252, XP019489181, ISSN: 1432-1041, DOI: 10.1007/S00228-006-0249-1 (B1)
KOZUE KUBO ET AL: "Successful management of cesarean section in a patient with Romano-Ward syndrome using landiolol, a selective and short-acting [beta]1 receptor antagonist", JOURNAL OF ANESTHESIA, SPRINGER-VERLAG, TO, vol. 19, no. 2, 1 May 2005 (2005-05-01), pages 174-176, XP019373359, ISSN: 1438-8359, DOI: 10.1007/S00540-005-0302-8 (B1)
MIWA YOSUKE ET AL: "Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.", CIRCULATION JOURNAL : OFFICIAL JOURNAL OF THE JAPANESE CIRCULATION SOCIETY MAY 2010, vol. 74, no. 5, 1 May 2010 (2010-05-01), pages 856-863, XP002712727, ISSN: 1347-4820 (B1)
WARIISHI SEIICHIRO ET AL: "Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose", INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, OXFORD UNIVERSITY PRESS, UK, vol. 9, no. 5, 1 November 2009 (2009-11-01), pages 811-813, XP008164714, ISSN: 1569-9293, DOI: 10.1510/ICVTS.2009.212837 (B1)
NAGAI RYOZO ET AL: "Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting [beta]1-selective blocker landiolol with digoxin (J-Land Study).", CIRCULATION JOURNAL : OFFICIAL JOURNAL OF THE JAPANESE CIRCULATION SOCIETY 2013, vol. 77, no. 4, 2013, pages 908-916, XP002712699, ISSN: 1347-4820 (B1)
SHINJI TAKAHASHI ET AL: "Modifications of the hemodynamic consequences of theophylline intoxication with landiolol in halothane-anesthetized dogs", CANADIAN JOURNAL OF ANESTHESIA, vol. 47, no. 3, 1 March 2000 (2000-03-01), pages 265-272, XP055078074, ISSN: 0832-610X, DOI: 10.1007/BF03018925 (B1)
T. NAKANO ET AL: "Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection", JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol. 37, no. 4, 7 August 2012 (2012-08-07) , pages 431-435, XP055135833, ISSN: 0269-4727, DOI: 10.1111/j.1365-2710.2011.01315.x (B1)
TAKAHASHI S ET AL: "Landiolol decreases a dysrhythmogenic dose of epinephrine in dogs during halothane anesthesia.", CANADIAN JOURNAL OF ANAESTHESIA = JOURNAL CANADIEN D'ANESTHÉSIE JUN 1999, vol. 46, no. 6, June 1999 (1999-06), pages 599-604, XP002728764, ISSN: 0832-610X (B1)
MORISAKI AKIMASA ET AL: "Very-low-dose continuous drip infusion of landiolol hydrochloride for postoperative atrial tachyarrhythmia in patients with poor left ventricular function.", GENERAL THORACIC AND CARDIOVASCULAR SURGERY JUN 2012, vol. 60, no. 6, June 2012 (2012-06), pages 386-390, XP002712698, ISSN: 1863-6713 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP2988750)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 11. avg. år (EP) | 2024.03.08 | 4550 | ABP Patent Network GmbH | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2023.04.14 | 3200 | ABP Patent Network GmbH | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2022.04.25 | 2850 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
32205071 expand_more expand_less | 2022.04.06 | 5500 | Murgitroyd & Company | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|